KEYTRUDA® (pembrolizumab) Plus WELIREG® (belzutifan) Given as Adjuvant Therapy Reduced the Risk of Disease Recurrence or Death by 28% Compared to KEYTRUDA Monotherapy in Certain Patients With Earlier-Stage Renal Cell Carcinoma (RCC)
This is the first positive Phase 3 trial for WELIREG in earlier-stage disease, the first positive results for a HIF-2α inhibitor and immunotherapy combination and... Read more.
WELIREG® (belzutifan) Plus LENVIMA® (lenvatinib) Reduced the Risk of Disease Progression or Death by 30% Compared to Cabozantinib in Certain Previously Treated Patients With Advanced Renal Cell Carcinoma (RCC)
This is the first positive Phase 3 trial of a HIF-2 alpha inhibitor in combination with a multi-targeted tyrosine kinase inhibitor, the first for patients with RCC... Read more.
Berkshire Hathaway Inc. News Release
OMAHA, Neb.–(BUSINESS WIRE)–(BRK.A; BRK.B) – Berkshire’s operating results for the fourth quarter and full year of 2025 and 2024 are summarized in... Read more.
Biocytogen Announces Clinical Milestone with First Patient Dosed in Phase 1 Trial of IDEAYA’s First-in-Class B7H3/PTK7 Bispecific TOP1 ADC IDE034
IDE034 is a B7H3/PTK7 bispecific TOP1 ADC designed to target tumor cells expressing both B7H3 and PTK7 preferentially, and is being evaluated as monotherapy and... Read more.
Biocytogen Announces Clinical Milestone with First Patient Dosed in Phase 1 Trial of IDEAYA’s First-in-Class B7H3/PTK7 Bispecific TOP1 ADC IDE034
IDE034 is a B7H3/PTK7 bispecific TOP1 ADC designed to target tumor cells expressing both B7H3 and PTK7 preferentially, and is being evaluated as monotherapy and... Read more.
Secretary of War Pete Hegseth Visits L3Harris Solid Rocket Motor Site
CAMDEN, Ark.–(BUSINESS WIRE)–Secretary of War Pete Hegseth visited the L3Harris Technologies (NYSE: LHX) Camden site today as part of his nationwide... Read more.
National Condom Month: Why Today’s Protection Is About Pleasure, Confidence and Connection, According to Sex & Relationship Expert, Dr. Deb Laino
PHILADELPHIA–(BUSINESS WIRE)–In recognition of National Condom Month, sex and relationship therapist Dr. Deb Laino is encouraging young adults to prioritize... Read more.
The Baldwin Group Announces Future Leadership Transition in its Underwriting, Capacity, and Technology Solutions Segment
Amy Carlisle to be named CEO; Jim Roche to become Executive Chairman TAMPA, Fla.–(BUSINESS WIRE)–The Baldwin Group (“Baldwin” or the “Company”)... Read more.
PSFE INVESTOR REMINDER: Paysafe Limited Investors Have Until April 7, 2026 To Seek Lead Plaintiff Role
NEW YORK–(BUSINESS WIRE)–If you have suffered a loss on your Paysafe Limited (“Paysafe” or the “Company”) (NYSE:PSFE) investment, contact Lauren... Read more.
INVESTOR ALERT: Securities Class Action Filed Against Franklin BSP Realty Trust, Inc. – Investors Encouraged to Contact Kirby McInerney LLP
NEW YORK–(BUSINESS WIRE)–The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed on behalf of investors who acquired... Read more.